CQ | AI-Powered Asset Management Software for Smarter Fundraising

Smart deals start with the right connections.

Access 800+ qualified LPs through CQ’s Investor Database.

Karolinska Development

Venture Capital Firm,Private Equity Firm

Karolinska Development AB is an investment firm focused on identifying and nurturing medical innovations, supporting the development of pharmaceutical and medtech companies into differentiated products that significantly impact patients' lives while delivering attractive returns.

Overview and Management

Establishment Year

2003

Mission

We believe that investments should be meaningful and impactful. Our approach is centered on identifying and nurturing companies that have the potential to make significant contributions to the life sciences field.

Values

Commitment to sustainability, societal advancement, and innovative healthcare solutions. Focus on ESG aspects, governance, and creating long-term value for human health.

Investment Roles

Direct Investor,General Partner (GP)

Participant Demographics

Serves a range of stakeholders, including investors aiming to participate in life sciences innovations, and supports portfolio companies developing groundbreaking medical treatments.

Generational Wealth Planning

Risk Tolerance

Focuses on reducing risks through diversification, syndication, and structured development programs, with a preference for innovative and high-potential projects.

References or Case Studies

Provides detailed performance insights and case studies about its portfolio companies and investment successes.

Team Experience

Comprised of professionals with extensive expertise in life sciences and commercialization.

Notable Achievements

Successful IPOs, strategic exits, and partnerships, including Forendo Pharma's acquisition by Organon for up to USD 945 million.

Project Track Record

Investments in several high-value life science projects, including Aprea Therapeutics and Forendo Pharma.

Exit Strategies

Licensing deals, IPOs, and trade sales post-clinical phase II or commercialization.

Legal, Compliance and Contact Information

Regulatory Registrations

Swedish Companies Act and Swedish Code of Corporate Governance.

Compliance History

No major violations.

Email

info@karolinskadevelopment.com

Phone Number

+46 8 524 860 70

Address

Solna Sweden

Scroll to Top